Thiazoline and phthalimides derivatives as Mycobacterium tuberculosis MurB inhibitors: A molecular docking study

Vol 2, 2022 - 153243
Poster
Favoritar este trabalho
Como citar esse trabalho?
Resumo

The development of resistant strains of Mycobacterium tuberculosis (Mtb) is a big concern, which highlights the need of discovering new antibiotics1. Recent studies investigated molecular targets in earlier steps of peptidoglycan synthesis to discover new drugs for tuberculosis treatment2. These findings led us to select the enzyme UDP-N-acetylenolpyruvoylglucosamine reductase (MurB) due to its essential role in peptidoglycan synthesis and no eukaryote homologue2. Andres and coworkers discovered 4-thiazolidinones as MurB inhibitors at a micromolar level3. This way, we are proposing thiazoline and phthalimide derivatives as MurB inhibitors. Molecular docking studies were performed with MurB4 in complex with the proposed heterocycles with several aromatic substituents (electronic and steric effects) and their precursors, which resulted in more than 150 molecules. Interactions with key residues in MurB catalysis such as Arg176, Glu361 and Ser257 were observed, also theoretical Ki at low micromolar range. These results may guide the discovery of new antibiotics against Mtb.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Instituições
  • 1 Agreste Academic Centre, Universidade Federal de Pernambuco - UFPE
  • 2 Department of Fundamental Chemistry, Universidade Federal de Pernambuco - UFPE
Eixo Temático
  • 1. Strategies in Drug Design
Palavras-chave
Drug Discovery
heterocyclic chemistry
Tuberculosis
antimicrobial agents